Duality Advisers, LP Uni Qure N.V. Transaction History

Duality Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$14.54 - $21.5 $1.05 Million - $1.55 Million	-71,928 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$20.24 - $36.01 $1.46 Million - $2.59 Million	71,928 New	71,928 $1.49 Million
Q4 2020 Feb 09, 2021	SELL	$35.35 - $50.67 $202,909 - $290,845	-5,740 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $206,525 - $273,568	5,740 New	5,740 $211,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.